Relapse or persistent disease after two years showed a trend toward improvement at 15.6% for NAC vs. 19.5% for adjuvant chemotherapy, but did not meet statistical significance (HR = 0.76, 95% confidence interval (CI 0.56–1.02; p = 0.07).
1
—
—
Relapse or persistent disease after two years showed a trend toward improvement at 15.6% for NAC vs. 19.5% for adjuvant chemotherapy, but did not meet statistical significance (HR = 0.76, 95% confidence interval (CI 0.56–1.02; p = 0.07).